Monopar Therapeutics (MNPR) Treasury Shares (2020 - 2025)
Quarterly results put Treasury Shares at $175634.0 for Q4 2025, up 331.12% from a year ago — trailing twelve months through Dec 2025 was $175634.0 (up 331.12% YoY), and the annual figure for FY2025 was $175634.0, up 331.12%.
Monopar Therapeutics has reported Treasury Shares over the past 6 years, most recently at $175634.0 for Q4 2025.
- Treasury Shares reached $175634.0 in Q4 2025 per MNPR's latest filing, up from $114610.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $525565.0 in Q2 2023 and bottomed at $40739.0 in Q4 2024.
- Median Treasury Shares over the past 5 years was $149364.0 (2025), compared with a mean of $218852.2.
- The largest annual shift saw Treasury Shares crashed 89.86% in 2024 before it soared 331.12% in 2025.
- Over 5 years, Treasury Shares stood at $111462.0 in 2021, then plummeted by 51.08% to $54529.0 in 2022, then skyrocketed by 53.34% to $83617.0 in 2023, then plummeted by 51.28% to $40739.0 in 2024, then skyrocketed by 331.12% to $175634.0 in 2025.
- Business Quant data shows Treasury Shares for MNPR at $175634.0 in Q4 2025, $114610.0 in Q3 2025, and $128408.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 700,000.00 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 34.70 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | - |
| 10 | Monopar Therapeutics | 466.82 Mn | 466.82 Mn | - | 175,634.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 175,634.00 |
| Dec 31, 2025 | 175,634.00 |
| Sep 30, 2025 | 114,610.00 |
| Sep 30, 2025 | 114,610.00 |
| Jun 30, 2025 | 128,408.00 |
| Jun 30, 2025 | 128,408.00 |
| Mar 31, 2025 | 149,364.00 |
| Mar 31, 2025 | 149,364.00 |
| Dec 31, 2024 | 40,739.00 |
| Dec 31, 2024 | 40,739.00 |
| Sep 30, 2024 | 47,843.00 |
| Sep 30, 2024 | 47,843.00 |
| Jun 30, 2024 | 349,154.00 |
| Jun 30, 2024 | 349,154.00 |
| Mar 31, 2024 | 366,534.00 |
| Mar 31, 2024 | 366,534.00 |
| Dec 31, 2023 | 83,617.00 |
| Dec 31, 2023 | 83,617.00 |
| Sep 30, 2023 | 471,828.00 |
| Sep 30, 2023 | 471,828.00 |
| Jun 30, 2023 | 525,565.00 |
| Jun 30, 2023 | 525,565.00 |
| Dec 31, 2022 | 54,529.00 |
| Dec 31, 2022 | 54,529.00 |
| Sep 30, 2022 | 307,202.00 |
| Sep 30, 2022 | 307,202.00 |
| Jun 30, 2022 | 341,753.00 |
| Jun 30, 2022 | 341,753.00 |
| Mar 31, 2022 | 483,052.00 |
| Mar 31, 2022 | 483,052.00 |
| Dec 31, 2021 | 111,462.00 |
| Dec 31, 2021 | 111,462.00 |
| Sep 30, 2021 | 122,773.00 |
| Sep 30, 2021 | 122,773.00 |
| Jun 30, 2021 | 132,706.00 |
| Jun 30, 2021 | 132,706.00 |
| Mar 31, 2021 | 151,419.00 |
| Mar 31, 2021 | 151,419.00 |
| Dec 31, 2020 | 40,066.00 |
| Dec 31, 2020 | 40,066.00 |
| Sep 30, 2020 | 41,854.00 |
| Sep 30, 2020 | 41,854.00 |
| Jun 30, 2020 | 43,142.00 |
| Jun 30, 2020 | 43,142.00 |
| Mar 31, 2020 | 44,434.00 |
| Mar 31, 2020 | 44,434.00 |